HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)

MLA

Jürgen Debus, et al. “HPV16 DNA Status Is a Strong Prognosticator of Loco-Regional Control after Postoperative Radiochemotherapy of Locally Advanced Oropharyngeal Carcinoma: Results from a Multicentre Explorative Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).” Radiotherapy and Oncology, vol. 113, no. 3, Dec. 2014, pp. 317–23. EBSCOhost, https://doi.org/10.1016/j.radonc.2014.11.011.

APA

Jürgen Debus, Amir Abdollahi, Fabian Lohaus, Melanie Avlar, Anca-Ligia Grosu, Annett Linge, Claus Rödel, Eleni Gkika, Steffen Löck, Daniel Zips, Christine Bayer, Mechthild Krause, Howard D. Thames, Gustavo B. Baretton, Michael Baumann, Volker Budach, David Mönnich, Cläre von Neubeck, Inge Tinhofer, … Stephanie E. Combs. (2014). HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiotherapy and Oncology, 113(3), 317–323. https://doi.org/10.1016/j.radonc.2014.11.011

Chicago

Jürgen Debus, Amir Abdollahi, Fabian Lohaus, Melanie Avlar, Anca-Ligia Grosu, Annett Linge, Claus Rödel, et al. 2014. “HPV16 DNA Status Is a Strong Prognosticator of Loco-Regional Control after Postoperative Radiochemotherapy of Locally Advanced Oropharyngeal Carcinoma: Results from a Multicentre Explorative Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).” Radiotherapy and Oncology 113 (3): 317–23. doi:10.1016/j.radonc.2014.11.011.